Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Biogen
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Have a confirmed diagnosis of RRMS and satisfy the therapeutic indication as described in the local label.
Female subjects of childbearing potential who are not surgically sterile must practice effective contraception according to the summary of product characteristics (SPC) during their participation in the study and be willing and able to continue contraception for 30 days after their last dose of study treatment.
You may not be if
Diagnosis of primary progressive, secondary progressive or progressive relapsing MS.
Antibiotic treatment in the last month prior to study entry.
Scheduled alteration of diet, including the use of probiotics.
